Literature DB >> 25979376

Development of fluorescent peptide substrates and assays for the key autophagy-initiating cysteine protease enzyme, ATG4B.

Lubomir Vezenkov1, Nicolette S Honson2, Nag S Kumar2, Damien Bosc1, Suzana Kovacic1, Thanh G Nguyen1, Tom A Pfeifer2, Robert N Young3.   

Abstract

An efficient assay for monitoring the activity of the key autophagy-initiating enzyme ATG4B based on a small peptide substrate has been developed. A number of putative small fluorogenic peptide substrates were prepared and evaluated and optimized compounds showed reasonable rates of cleavage but required high enzyme concentrations which limited their value. A modified peptide substrate incorporating a less sterically demanding self-immolative element was designed and synthesized and was shown to have enhanced properties useful for evaluating inhibitors of ATG4B. Substrate cleavage was readily monitored and was linear for up to 4h but enzyme concentrations of about ten-fold higher were required compared to assays using protein substrate LC3 or analogs thereof (such as FRET-LC3). Several known inhibitors of ATG4B were evaluated using the small peptide substrate and gave IC50 values 3-7 fold higher than previously obtained values using the FRET-LC3 substrate.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ATG4B; Autophagy; Cysteine protease; Fluorogenic peptide; Inhibitor; LC3; Screen; Substrate

Mesh:

Substances:

Year:  2015        PMID: 25979376     DOI: 10.1016/j.bmc.2015.04.064

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  7 in total

1.  Discovery of a small molecule targeting autophagy via ATG4B inhibition and cell death of colorectal cancer cells in vitro and in vivo.

Authors:  Yuanyuan Fu; Liang Hong; Jiecheng Xu; Guoping Zhong; Qiong Gu; Qianqian Gu; Yanping Guan; Xueping Zheng; Qi Dai; Xia Luo; Cui Liu; Zhiying Huang; Xiao-Ming Yin; Peiqing Liu; Min Li
Journal:  Autophagy       Date:  2018-09-20       Impact factor: 16.016

Review 2.  Measurement of the Activity of the Atg4 Cysteine Proteases.

Authors:  M Li; Y Fu; Z Yang; X-M Yin
Journal:  Methods Enzymol       Date:  2016-12-05       Impact factor: 1.600

Review 3.  On ATG4B as Drug Target for Treatment of Solid Tumours-The Knowns and the Unknowns.

Authors:  Alexander Agrotis; Robin Ketteler
Journal:  Cells       Date:  2019-12-24       Impact factor: 6.600

4.  ATG 4B Serves a Crucial Role in RCE-4-Induced Inhibition of the Bcl-2-Beclin 1 Complex in Cervical Cancer Ca Ski Cells.

Authors:  Fang-Fang You; Jing Zhang; Fan Cheng; Kun Zou; Xue-Qing Zhang; Jian-Feng Chen
Journal:  Int J Mol Sci       Date:  2021-11-14       Impact factor: 5.923

5.  Precision autophagy: Will the next wave of selective autophagy markers and specific autophagy inhibitors feed clinical pipelines?

Authors:  Chandra B Lebovitz; Lindsay DeVorkin; Damien Bosc; Katharina Rothe; Jagbir Singh; Marcel Bally; Xiaoyan Jiang; Robert N Young; Julian J Lum; Sharon M Gorski
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

Review 6.  Recent insights into the function of autophagy in cancer.

Authors:  Ravi Amaravadi; Alec C Kimmelman; Eileen White
Journal:  Genes Dev       Date:  2016-09-01       Impact factor: 11.361

7.  A new quinoline-based chemical probe inhibits the autophagy-related cysteine protease ATG4B.

Authors:  D Bosc; L Vezenkov; S Bortnik; J An; J Xu; C Choutka; A M Hannigan; S Kovacic; S Loo; P G K Clark; G Chen; R N Guay-Ross; K Yang; W H Dragowska; F Zhang; N E Go; A Leung; N S Honson; T A Pfeifer; M Gleave; M Bally; S J Jones; S M Gorski; R N Young
Journal:  Sci Rep       Date:  2018-08-03       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.